Who owns ONCOCYTE CORPORATION COM?
- Ticker: OCX
- CUSIP Number: 68235c206
Tip: Access positions for across all investors
Analyze quarterly positions in Oncocyte Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Oncocyte Corporation stock
Who bought or sold ONCOCYTE CORPORATION COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 248k | $620k | 3% | Dec 2023 |
|
UBS Group | 1.4k | $3.4k | 35% | Dec 2023 |
|
Royal Bank of Canada | 901.00 | $2.0k | -12% | Dec 2023 |
|
Pnc Financial Services | 500.00 | $1.3k | 0% | Dec 2023 |
|
Bank of America Corporation | 216.00 | $540.496800 | 3% | Dec 2023 |
|
Jpmorgan Chase & Co | 154.00 | $381.997000 | 0% | Dec 2023 |
|
Nbc Securities | 150.00 | $1.0k | 100% | Mar 2024 |
|
Advisor Group Holdings | 97.00 | $241.471800 | -92% | Dec 2023 |
|
Rhumbline Advisers | 66.00 | $163.996800 | 0% | Dec 2023 |
|
Wells Fargo & Company | 60.00 | $150.000000 | 3% | Dec 2023 |
|
Riggs Asset Managment | 50.00 | $125.000000 | 0% | Dec 2023 |
|
Piscataqua Savings Bank | 25.00 | $73.000000 | 0% | Mar 2024 |
|
Coppell Advisory Solutions | 10.00 | $25.000000 | 100% | Dec 2023 |
|
Albion Financial Group | 7.00 | $21.000000 | 0% | Mar 2024 |
|
Who sold out of Oncocyte Corporation?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Millennium Management | Sep 2023 | 15k | $48k |
Us Bancorp | Sep 2023 | 25.00 | $78.000000 |
Meeder Asset Management | Sep 2023 | 9.00 | $27.999900 |
Lindbrook Capital | Dec 2023 | 4.00 | $10.000000 |